|
MechanismPARP-7 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Baiguo Yukang Information Service Co., Ltd.
0 Patents (Medical) associated with Baiguo Yukang Information Service Co., Ltd.
100 Deals associated with Baiguo Yukang Information Service Co., Ltd.
100 Translational Medicine associated with Baiguo Yukang Information Service Co., Ltd.